The effect of leukotrienes C4 (LTC4) and D4 (LTD4) and prostaglandin E2 (PGE2) on mucociliary clearance of the eustachian tube was investigated in vitro and in vivo. Normal ciliated epithelium was obtained from the eustachian tube of guinea pigs and incubated separately with LTC4, LTD4, and PGE2 at concentrations of 10−8 mol/L and 10−6 mol/L. Ciliary activity was measured photoelectrically. Leukotriene D4 progressively inhibited ciliary activity, while PGE2 promoted it. Leukotriene C4 also induced ciliary inhibition. One milliliter each of 10−5 mol/L LTC4, LTD4, and PGE2 was directly injected into the tympanic bullae of chinchillas under anesthesia. The middle ears were examined by otomicroscopy, tympanometry, and auditory brain stem response over time. Clearance of middle ear effusion was delayed by LTC4 and LTD4, as compared with PGE2 and the control. These findings indicate that LTC4 and LTD4 inhibit mucociliary clearance of the eusiachian tube.
HonjoIOkazakiNNozoeTUshiroKKumazawaT. Experimental study of the pumping function of the eustachian tube. Acta Otolaryngol (Stockh)1981;91: 85–9.
2.
SadéJ. Ciliary activity and middle ear clearance. Arch Otolaryngol1967;86: 128–35.
3.
KärjäJNuutinenJKarjalainenP. Mucociliary function in children with secretory otitis media. Acta Otolaryngol (Stockh)1983;95: 544–6.
4.
TakahashiHHayashiMKurataKHonjoI. Eustachian tube function in cases of otitis media with effusion. Pract Otol (Kyoto)1986;79: 1589–97.
5.
BluestoneCDParadiseJLBeeryQC. Symposium on prophylaxis and treatment of middle ear effusions. IV. Physiology of the eustachian tube in the pathogenesis and management of middle ear effusions. Laryngoscope1972;82: 1654–70.
6.
SakuraiTKobayashiTTakeyamaMSuzukiMBabaS. Evaluation of eustachian tubal functions in patients with otitis media with effusion. J Otolaryngol Japan1985;88: 273–8.
7.
TakahashiHHayashiMSatoHHonjoI. Primary deficits in eustachian tube function in patients with otitis media with effusion. Arch Otolaryngol Head Neck Surg1989;115: 581–4.
8.
IshiiTToriyamaMSuzukiJ-I. Histopathological study of otitis media with effusion. Ann Otol Rhinol Laryngol1980;89(supp1 68): 83–6.
9.
SadeJ. Pathology and pathogenesis of serous otitis media. Arch Otolaryngol1966;84: 297–305.
10.
JungTTK. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope1988;98: 980–93.
11.
JacksonRTWaitzmanMBPickfordLNathansonSE. Prostaglandins in human middle ear effusions. Prostaglandins1975;10: 365–71.
12.
BernsteinJMOkazakiTReismanRE. Prostaglandins in middle ear effusions. Arch Otolaryngol1976;102: 257–8.
13.
GanboTHisamatsuK. Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol (Stockh)1990;110: 427–36.
14.
WannerAMaurerDAbrahamWMSzepfalusiZSielczakM. Effects of chemical mediators of anaphylaxis on ciliary function. J Allergy Clin Immunol1983;72: 663–7.
15.
BisgaardHPedersenM. SRS-A leukotrienes decrease the activity of human respiratory cilia. Clin Allergy1987;17: 95–103.
16.
WeismanZFinkAAlonA. Leukotriene C4 decreases the activity of respiratory cilia in vitro. Clin Exp Allergy1990;20: 389–93.
17.
SamuelssonB. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science1983;220: 568–75.
18.
KuoCGLewisMTJakschikBA. Leukotriene D4 and E4 formation by plasma membrane bound enzymes. Prostaglandins1984;28: 929–38.
19.
WannerASielczakMMellaJFAbrahamWM. Ciliary responsiveness in allergic and nonallergic airways. J Appl Physiol1986;60: 1967–71.
20.
BakaletzLOGriffithSRLimDJ. Effect of prostaglandin E2 and bacterial endotoxin on the rate of dye transport in the eustachian tube of the chinchilla. Ann Otol Rhinol Laryngol1989;98: 278–82.
21.
WilliamsTJMorleyJ. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature1973;246: 215–7.
22.
WilliamsTJPeckMJ. Role of prostaglandin-mediated vasodilatation in inflammation. Nature1977;270: 530–2.
23.
DennisRGWhitmireRNJacksonRT. Action of inflammatory mediators on middle ear mucosa. A method for measuring permeability and swelling. Arch Otolaryngol1976;102: 420–4.
24.
JungTTKParkYMSchlundD. Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol1990;99(supp1 148): 28–32.
25.
JungTTKParkYMMillerSKRozehnalSWooHYBaerW. Effect of exogenous arachidonic acid metabolites applied on round window membrane on hearing and their levels in the perilymph. Acta Otolaryngol [Suppl] (Stockh) 1992(suppl 493): 171–6.
26.
UenoATanakaKKatoriMHayashiMAraiY. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins1981;21: 637–47.
27.
MaromZShelhamerJHBachMKMortonDRKalinerM. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis1982;126: 449–51.
28.
MinamiTKuboNTomodaKKumazawaT. Effects of various inflammatory mediators on eustachian tube patency. Acta Otolaryngol (Stockh)1992;112: 680–5.
